EurekAlert! -
4 Jan 2021 07:00
(H. Lee Moffitt Cancer Center & Research Institute) Moffitt Cancer Center researchers are investigating whether inflammation in the body, a side effect of ADT, contributes to these symptoms in prostate cancer patients. In a new study published in the journal Cancer, they pinpoint a specific inflammation marker that is associated with increased fatigue in this group of patients.
Share this Article